MAGENTA THERAPEUTICS INC's ticker is MGTA and the CUSIP is 55910K108. A total of 95 filers reported holding MAGENTA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $113,169 | -26.4% | 149,300 | -22.8% | 0.00% | – |
| Q1 2023 | $153,774 | +101.2% | 193,500 | 0.0% | 0.00% | – |
| Q4 2022 | $76,433 | -72.0% | 193,500 | 0.0% | 0.00% | – |
| Q3 2022 | $273,000 | +17.7% | 193,500 | -0.0% | 0.00% | – |
| Q2 2022 | $232,000 | -58.8% | 193,516 | -0.4% | 0.00% | – |
| Q1 2022 | $563,000 | -34.6% | 194,290 | -0.1% | 0.00% | – |
| Q4 2021 | $861,000 | -24.4% | 194,420 | +24.3% | 0.00% | -100.0% |
| Q3 2021 | $1,139,000 | +178.5% | 156,375 | +273.9% | 0.00% | – |
| Q2 2021 | $409,000 | -19.8% | 41,820 | -3.0% | 0.00% | – |
| Q1 2021 | $510,000 | +12.1% | 43,115 | -25.7% | 0.00% | – |
| Q4 2020 | $455,000 | +21.7% | 58,039 | +5.6% | 0.00% | – |
| Q3 2020 | $374,000 | +146.1% | 54,974 | +171.0% | 0.00% | – |
| Q2 2020 | $152,000 | +34.5% | 20,286 | +12.4% | 0.00% | – |
| Q1 2020 | $113,000 | – | 18,047 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 6,758,204 | $49,200,000 | 11.16% |
| Aquilo Capital Management, LLC | 3,155,082 | $22,969,000 | 4.17% |
| GREAT POINT PARTNERS LLC | 1,170,000 | $8,518,000 | 1.98% |
| Casdin Capital, LLC | 3,901,589 | $28,404,000 | 0.71% |
| Alphabet Inc. | 3,339,138 | $24,309,000 | 0.58% |
| Bleichroeder LP | 434,400 | $3,162,000 | 0.51% |
| Palo Alto Investors LP | 432,300 | $3,147,000 | 0.19% |
| Integral Health Asset Management, LLC | 90,000 | $655,000 | 0.19% |
| Orbimed Advisors | 1,892,953 | $13,781,000 | 0.15% |
| HARVARD MANAGEMENT CO INC | 332,610 | $2,421,000 | 0.14% |